Research Database

42 studies found

Positive

83.3%

Negative

0.0%

Inconclusive

16.7%

Page 1 of 3

InconclusiveReview/Other

Use of non-medical cannabis in epilepsy: A scoping review

2023

Alzheimer's DiseaseAmyotrophic Lateral Sclerosis (ALS)Anorexia+9

PositiveReview/Other

The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?

2022

Amyotrophic Lateral Sclerosis (ALS)

PositiveReview/Other

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?

2022

Alzheimer's Disease

PositiveMeta-analysis -

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

2022

ADD and ADHD

PositiveReview/Other

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents

2022

Alzheimer's Disease

PositiveAnimal Study - Veterinary Clinical Trial

Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

2022

Cognitive Dysfunction

PositiveReview/Other

Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report

2021

Amyotrophic Lateral Sclerosis (ALS)

PositiveReview/Other

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

2021

Neurodegenerative Issues

PositiveReview/Other

Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

2021

Amyotrophic Lateral Sclerosis (ALS)

PositiveReview/Other

The Role of Cannabidiol in Neurological Disorders

2021

Addiction

InconclusiveReview/Other

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

2021

Amyotrophic Lateral Sclerosis (ALS)

PositiveMeta-analysis -

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review

2020

Inflammation

InconclusiveReview/Other

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?

2020

Alzheimer's Disease

PositiveReview/Other

Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells

2020

Oxidative Stress

PositiveMeta-analysis -

Can we turn mice into men?: An Editorial for Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis page 284.

2019

Amyotrophic Lateral Sclerosis (ALS)

InconclusiveDouble Blind Clinical Trial

Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial

2019

Addiction

PositiveReview/Other

Priority Considerations for Medicinal Cannabis-Related Research

2019

Alzheimer's Disease

Command Palette

Research Database

Use of non-medical cannabis in epilepsy: A scoping review

The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents

Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

The cannabinoid system and microglia in health and disease

Cannabinoid Quinones—A Review and Novel Observations

Emerging potential of cannabidiol in reversing proteinopathies

Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

The Role of Cannabidiol in Neurological Disorders

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?

Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells

Can we turn mice into men?: An Editorial for Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis page 284.

Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial

Priority Considerations for Medicinal Cannabis-Related Research